AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,000 | 0.0% | 539 | -18.6% | 0.00% | – |
| Q3 2019 | $13,000 | -7.1% | 662 | +33.7% | 0.00% | – |
| Q2 2019 | $14,000 | +7.7% | 495 | +79.3% | 0.00% | – |
| Q1 2019 | $13,000 | +550.0% | 276 | +278.1% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 73 | -11.0% | 0.00% | – |
| Q3 2018 | $5,000 | +25.0% | 82 | +12.3% | 0.00% | – |
| Q2 2018 | $4,000 | -20.0% | 73 | -24.7% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 97 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | +25.0% | 97 | +32.9% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +100.0% | 73 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -94.3% | 73 | -92.3% | 0.00% | -100.0% |
| Q3 2016 | $35,000 | – | 951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |